Oculis
first eye drop for results consistent with previous trials | Oculis
Company
Deck Type
Deck date
May 2023
Slide
8 of 30
Similar slides by Oculis
See diffirences between slides (animation)
Investor Presentation
July 2023
first eye drop for | Oculis
Investor Conference
June 2023
first eye drop for | Oculis
Investor Presentation
April 2023
first eye drop for | Oculis
Related slides by other companies
Dare Bioscience
Investor Presentation
October 2022
cream phase and phase a study results | Dare Bioscience
Dare Bioscience
Investor Presentation
February 2023
cream phase and phase a study results parameter | Dare Bioscience
ATAI
Investor Presentation
January 2023
achieved and expected milestones key achievements to date phase results phase results initiation of clinical programs phase results phase a results phase results phase results phase results phase results phase a results phase first subject dosed phase results anorexia efficacy study results efficacy study first subject dosed in cash as of plus access to up to an additional from term loan facility provides runway expected into we expect deliver several meaningful anticipated across our through with | ATAI
Bausch Health Companies
Results
February 2022
pipeline and portfolio expansion late stage development development salix | Bausch Health Companies
Other recent decks by Oculis
See all presentations (6 decks)
Results
August 2023
Investor Presentation
July 2023
Investor Conference
June 2023
Investor Presentation
April 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io